SAFER Banking Act 2026: Congressional Momentum Builds as Schedule III Rescheduling Reshapes the Cannabis Finance Landscape
TL;DR: The SAFER Banking Act — the cannabis industry’s most consequential pending financial legislation — is gaining renewed momentum in the 119th Congress as the DEA’s Schedule III administrative hearing nears its final evidentiary phase. With rescheduling expected to resolve the fundamental federal conflict over cannabis commerce, banking access reform is emerging as the logical […]
Tilray Brands Sunday Morning Brief: Beverage Pivot Matures as TLRY Positions for U.S. Cannabis Market Access
TL;DR: Tilray Brands (NASDAQ: TLRY) enters the final week of June 2026 with a fundamentally different business model than its Canadian LP peers — one built on beverage diversification, a dominant international medical cannabis footprint, and a strategic U.S. hemp-derived cannabinoid platform that positions the company for accelerated growth if federal rescheduling advances through the […]
Curaleaf Holdings Saturday Close: Rescheduling Hearing Conclusion and Multi-State Scale Anchor the July Catalyst Case
TL;DR: Curaleaf Holdings (OTCQX: CURLF), the largest US multi-state operator by store count, closes Saturday at a pivotal moment as DEA rescheduling hearings approach their final phase. The combination of a potential favorable ruling and ongoing 280E tax normalization creates a compounding earnings catalyst that disproportionately favors large-footprint operators. As investors position ahead of the […]
Canopy Growth Saturday Afternoon LP Review: Canopy USA Structure and International Medical Revenue Define the Post-Restructuring Thesis
TL;DR: Canopy Growth (Nasdaq: CGC) has spent the past 18 months restructuring its balance sheet and concentrating on two growth levers — international medical cannabis exports and the Canopy USA holding structure designed to capture U.S. MSO exposure the moment federal law permits. Saturday afternoon trading sees CGC consolidating in a range that reflects the […]
Verano Holdings Saturday Midday Brief: Illinois Dominance and 280E Tailwinds Set Up a Potential Q2 2026 Beat
TL;DR: Verano Holdings (OTC: VRNOF) enters the back half of 2026 with Illinois still its highest-margin market, Q2 earnings likely set up by 280E deductions already flowing through the books under April’s medical-rescheduling order, and a balance sheet restructured enough to reduce near-term dilution risk. Saturday midday price action reflects the broader cannabis sector’s constructive […]
Verano Holdings Saturday Midday Brief: Illinois Dominance and 280E Tailwinds Set Up a Potential Q2 2026 Beat
TL;DR: Verano Holdings (OTC: VRNOF) enters the back half of 2026 with Illinois still its highest-margin market, Q2 earnings likely set up by 280E deductions already flowing through the books under April’s medical-rescheduling order, and a balance sheet restructured enough to reduce near-term dilution risk. Saturday midday price action reflects the broader cannabis sector’s constructive […]
Innovative Industrial Properties Saturday Brief: Cannabis REIT Positioned as Rescheduling Unlocks Institutional Capital
TL;DR: Innovative Industrial Properties (NYSE: IIPR) — the cannabis sector’s only publicly traded REIT — is positioned to benefit as federal rescheduling progress begins normalizing the institutional risk calculus for cannabis-adjacent real estate. With MSOS sector equities at 2026 highs and operator balance sheets improving under reduced 280E burdens, demand for sale-leaseback financing is rising, […]
Trulieve Cannabis Saturday Brief: Florida Dominance and 280E Savings Create Multi-Year Earnings Leverage
TL;DR: Trulieve Cannabis (OTC: TCNNF) heads into the week of June 29 with a strengthened fundamental thesis as April’s federal medical rescheduling begins reducing its 280E tax burden. With the DOJ’s adult-use Schedule III hearings entering their final phase, Trulieve’s Florida-centric retail network — the largest single-state dispensary footprint in the U.S. — stands as […]
Cannabis Market Week-Ahead June 29: MSOS Locks 2026 Highs as Rescheduling Hearings Near Conclusion
TL;DR: Cannabis equities finished Friday, June 26 near session highs as the MSOS ETF extended its best weekly performance of 2026, buoyed by a second constructive day of DEA administrative rescheduling hearings. With the holiday-shortened week of June 29 ahead, investors will focus on rescheduling timeline developments, imminent Q2 earnings prints from top MSOs, and […]
Organigram Holdings Midday Review: BAT Partnership and EU Medical Exports Drive Q3 FY2026 Outperformance
TL;DR: Organigram Holdings (OGI) delivered strong Q3 FY2026 results, with net revenue of approximately C$52.3 million representing a 9% year-over-year gain, driven primarily by accelerating international medical cannabis exports to Germany and the United Kingdom. The British American Tobacco-backed Canadian LP continues to differentiate itself through its Centre of Excellence R&D program and export-first strategy […]